12:00 AM
 | 
Sep 15, 2003
 |  BC Week In Review  |  Clinical News  |  Clinical Status

AVAC: Phase II

GEN and SPA started a placebo-controlled New Zealand Phase II trial in 120 children ages 5-16.

Genesis Research...

Read the full 74 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >